Log In
    News

    BioSig Technologies (BSGM) Scheduled to Present at NobleCon18 Investor Conference

    4/4/2022
    Health
    0 min read

    BioSig Technologies CEO Kenneth Londoner provides a preview of their upcoming presentation at NobleCon18

    NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

    Free Registration Available – More Info


    Research News and Advanced Market Data on BSGM


    NobleCon18 Presenting Companies

    About BioSig

    BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com). The Company’s first product, PURE EP™ System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.
    Share
    Related News
    ‌
    Transatlantic HCLS M&A: The Talent Integration Mandate
    11/26/2025
    Health

    Transatlantic HCLS M&A: The Talent Integration Mandate

    The Healthcare and Life Sciences (HCLS) sector continues to be a powerhouse for global Mergers & Acquisitions (M&A) activity, driven by digitalization, specialized therapeutics, and the imperative for integrated care...
    8 min read
    ‌
    Hemisphere Energy (HMENF) – Third Quarter Results In Line with Expectations
    11/26/2025
    Energy

    Hemisphere Energy (HMENF) – Third Quarter Results In Line with Expectations

    Third quarter financial results. Hemisphere reported revenue of C$23.1 million in Q3, down from C$26.7 million in the prior-year period, but slightly above our estimate of C$21.6 million, due to better-than-expected...
    2 min read
    ‌
    GDEV (GDEV) – Efficient Capital Use Drives Improved 2025 Outlook
    11/26/2025
    Uncategorized

    GDEV (GDEV) – Efficient Capital Use Drives Improved 2025 Outlook

    Strong Q3 results. The company reported Q3 revenue of $97.6 million and adj. EBITDA of $26.7 million. While revenue was slightly below our estimate of $100.0 million, adj. EBITDA strongly outperformed...
    2 min read
    ‌
    Noble Capital Markets Research Morning Call
    11/26/2025
    Uncategorized

    Noble Capital Markets Research Morning Call

    Today’s Noble Capital Markets equity research reports, available with free Channelchek membership. ...
    79 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In